Abstract: The multiple-resistive-probabilistic-bit-per-cell has been firstly proposed to accelerate the computing of bio-genomic evolution, especially on the super virus (SARS-Cov-2) genome. With the ...
Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...
Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...
While Zenas’ obexelimab hit the primary endpoint in the Phase III INDIGO study, it came far below the efficacy threshold set by Amgen’s B cell depleter Uplizna, approved by the FDA for IgG4-related ...
LUND, SE / ACCESS Newswire / January 5, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV)(STO:BINV), a biotech company focused on the discovery and development of novel and first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results